One shot to smooth scars? new trial begins

NCT ID NCT07474467

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a single injection of TRTP-101, a biological treatment, to see if it safely improves atrophic scars (like acne scars). Thirty-one adults will receive the injection on one side of their face and a placebo on the other, with neither they nor their doctors knowing which is which. The goal is to measure scar improvement and any side effects over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

TRTP-101 (a biological injection)

What this could lead to

If it works, this could offer a new, one-time treatment to reduce the appearance of atrophic scars.

What could go wrong

This is an early, small trial (31 people) testing safety and effectiveness. The treatment may not work better than placebo, and there is a risk of side effects like skin reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATROPHIC SCAR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Samsung Medical Center

    Seoul, South Korea